149 related articles for article (PubMed ID: 30200497)
1. HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression.
Makarević J; Rutz J; Juengel E; Maxeiner S; Mani J; Vallo S; Tsaur I; Roos F; Chun FK; Blaheta RA
Cells; 2018 Sep; 7(9):. PubMed ID: 30200497
[TBL] [Abstract][Full Text] [Related]
2. Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanism.
Juengel E; Makarević J; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
Neoplasia; 2014 Apr; 16(4):291-300. PubMed ID: 24862756
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.
Juengel E; Najafi R; Rutz J; Maxeiner S; Makarevic J; Roos F; Tsaur I; Haferkamp A; Blaheta RA
Oncotarget; 2017 Dec; 8(66):110016-110028. PubMed ID: 29299126
[TBL] [Abstract][Full Text] [Related]
4. Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro.
Makarević J; Rutz J; Juengel E; Maxeiner S; Tsaur I; Chun FK; Bereiter-Hahn J; Blaheta RA
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31010254
[TBL] [Abstract][Full Text] [Related]
5. Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.
Tsaur I; Makarević J; Juengel E; Gasser M; Waaga-Gasser AM; Kurosch M; Reiter M; Wedel S; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Br J Cancer; 2012 Aug; 107(5):847-55. PubMed ID: 22782340
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions.
Juengel E; Meyer dos Santos S; Schneider T; Makarevic J; Hudak L; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Exp Biol Med (Maywood); 2013 Nov; 238(11):1297-304. PubMed ID: 24006305
[TBL] [Abstract][Full Text] [Related]
7. Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.
Wedel S; Hudak L; Seibel JM; Makarević J; Juengel E; Tsaur I; Wiesner C; Haferkamp A; Blaheta RA
Clin Exp Metastasis; 2011 Jun; 28(5):479-91. PubMed ID: 21452015
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro.
Juengel E; Natsheh I; Najafi R; Rutz J; Tsaur I; Haferkamp A; Chun FK; Blaheta RA
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31167517
[TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma
Engl T; Rutz J; Maxeiner S; Fanguen S; Juengel E; Koschade S; Roos F; Khoder W; Tsaur I; Blaheta RA
Oncotarget; 2018 Apr; 9(27):18747-18759. PubMed ID: 29721158
[TBL] [Abstract][Full Text] [Related]
10. Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.
Tsaur I; Hudak L; Makarević J; Juengel E; Mani J; Borgmann H; Gust KM; Schilling D; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
J Cell Mol Med; 2015 Aug; 19(8):1795-804. PubMed ID: 25808196
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism.
Siech C; Rutz J; Maxeiner S; Grein T; Sonnenburg M; Tsaur I; Chun FK; Blaheta RA
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053528
[TBL] [Abstract][Full Text] [Related]
12. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
Hudak L; Tezeeh P; Wedel S; Makarević J; Juengel E; Tsaur I; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
Prostate; 2012 Dec; 72(16):1719-35. PubMed ID: 22473339
[TBL] [Abstract][Full Text] [Related]
13. Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro.
Mani J; Neuschäfer J; Resch C; Rutz J; Maxeiner S; Roos F; Chun FK; Juengel E; Blaheta RA
Nutr Cancer; 2020; 72(3):528-537. PubMed ID: 31298931
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro.
Engl T; Rutz J; Maxeiner S; Juengel E; Roos F; Khoder W; Bechstein WO; Nelson K; Tsaur I; Haferkamp A; Blaheta RA
Mol Med Rep; 2017 Nov; 16(5):7064-7071. PubMed ID: 28901501
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1.
Lee JE; Kim JH
Genet Mol Biol; 2015 Dec; 38(4):527-33. PubMed ID: 26692161
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells.
Xia Q; Zheng Y; Jiang W; Huang Z; Wang M; Rodriguez R; Jin X
Oncol Lett; 2016 Sep; 12(3):1826-1832. PubMed ID: 27588130
[TBL] [Abstract][Full Text] [Related]
17. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
[TBL] [Abstract][Full Text] [Related]
18. Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
Wedel S; Hudak L; Seibel JM; Juengel E; Oppermann E; Haferkamp A; Blaheta RA
Prostate; 2011 May; 71(7):722-35. PubMed ID: 20954195
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro.
Juengel E; Engler J; Mickuckyte A; Jones J; Hudak L; Jonas D; Blaheta RA
BJU Int; 2010 Feb; 105(4):549-57. PubMed ID: 19594733
[TBL] [Abstract][Full Text] [Related]
20. Marine-derived chromopeptide A, a novel class I HDAC inhibitor, suppresses human prostate cancer cell proliferation and migration.
Sun JY; Wang JD; Wang X; Liu HC; Zhang MM; Liu YC; Zhang CH; Su Y; Shen YY; Guo YW; Shen AJ; Geng MY
Acta Pharmacol Sin; 2017 Apr; 38(4):551-560. PubMed ID: 28112184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
